Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study aims to verify if patients with nerve-related leg pain benefits from neurodynamic treatment over two weeks.
Nerve-related leg pain (NRLP) although less prevalent than low back pain itself, is associated with higher economic and social burden, and has been considered a predictor of chronicity and disability among subjects with low back pain.
Numerous approaches are proposed for its management; however, evidence regarding the best therapeutic approach is lacking. Neurodynamic techniques are proposed to be effective to manage NRLP.
Thus, this study aims to verify, through a randomized controlled trial, the effectiveness of a two-week program of neurodynamic techniques on pain and disability in individuals with NRLP.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Neurodynamic group | Experimental | Patients allocated to this group will receive three different neurodynamic techniques: a lumbar foramen dynamic opener; a side-lying slider and a slider in the slump position. Patients will be asked to perform home exercises (a slider and a tensioner technique). Treatment will receive four treatments during two weeks (two sessions/week). |
|
| Control Group | No Intervention | Patients allocated to Control Group (CG) will receive no intervention and will be advised according to the best evidence available; i.e, advice to remain active and to resume activities of daily living Upon trial completion, treatment will be offered. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Neurodynamic Group | Procedure | All techniques will be executed in a pain-free way (grade III). Mild discomfort will be accepted, but it must subside as soon as the technique ends.
|
| Measure | Description | Time Frame |
|---|---|---|
| Leg Pain Intensity | Leg Pain will be measured by a 0-10 Numeric Rating Scale (Pain NRS) | Two weeks after randomization |
| Disability | Disability will be measured by the Oswestry Disability Index (ODI) | Two weeks after randomization |
| Measure | Description | Time Frame |
|---|---|---|
| Leg pain Intensity | Leg Pain will me measured by a 0-10 Pain NRS | Four weeks after randomization |
| Disability | Disability will be measured by the Oswestry Disability Index (ODI) |
Not provided
Inclusion criteria:
Exclusion criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Marcelo F Silva, PhD | Federal University of Health Sciences of Porto Alegre | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Federal University of Health Sciences of Porto Alegre | Porto Alegre | Rio Grande do Sul | 90050-170 | Brazil |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 27634158 | Derived | Ferreira G, Stieven F, Araujo F, Wiebusch M, Rosa C, Plentz R, Silva M. Neurodynamic treatment did not improve pain and disability at two weeks in patients with chronic nerve-related leg pain: a randomised trial. J Physiother. 2016 Oct;62(4):197-202. doi: 10.1016/j.jphys.2016.08.007. Epub 2016 Aug 24. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
|
| Four weeks after randomization |
| Back pain intensity | Back Pain will me measured by an 0-10 Pain NRS | Two weeks after randomization |
| Back pain intensity | Back Pain will me measured by an 0-10 Pain NRS | Four weeks after randomization |
| Distribution of Symptoms | Distribution of symptoms will me measured by a body diagram | Two weeks, Four weeks after randomization |
| Function | Function will be measured by the Patient-Specific Functional Scale (PSFS) | Two weeks, Four weeks after randomization |
| Global Perceived Effect | Global Perceived Effect will be measured by an 11-point (-5 to +5) Global Perceived Effect Scale | Two weeks, Four weeks after randomization |
| ID | Term |
|---|---|
| D009437 | Neuralgia |
| D059348 | Peripheral Nerve Injuries |
| D010523 | Peripheral Nervous System Diseases |
| D012585 | Sciatica |
| D017116 | Low Back Pain |
| D012816 | Signs and Symptoms |
| ID | Term |
|---|---|
| D009468 | Neuromuscular Diseases |
| D009422 | Nervous System Diseases |
| D010146 | Pain |
| D009461 | Neurologic Manifestations |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D020196 | Trauma, Nervous System |
| D014947 | Wounds and Injuries |
| D020426 | Sciatic Neuropathy |
| D020422 | Mononeuropathies |
| D001416 | Back Pain |
Not provided
Not provided